Thinking Allowed
medical / technology / education / art / flub
What does the future of work look like for pharma?
The COVID-19 pandemic has accelerated changes to our working world. What does this mean for pharma, and what must the industry do to keep pace?
PwC - future of work for pharma
costs - pressures on efficienct, increasing R&D costs
sustainability and societal impact - pressure on companies to address issues
supply chain resilience - reshoring from India and China likely
precision medicine - focus on smaller patient groups
changing stakeholder influences - payers and patient influence on volume and prices
costs - pressures on efficienct, increasing R&D costs
sustainability and societal impact - pressure on companies to address issues
supply chain resilience - reshoring from India and China likely
precision medicine - focus on smaller patient groups
changing stakeholder influences - payers and patient influence on volume and prices
Source: www.pwc.co.uk
pwc pharma patient future likelyprecision costssustainability efficienct groupschanging
RSS feed